Bharat Immunolog

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE994B01014
NSEID:
BSEID: 524663

INR

22.49

0.42 (1.9%)

BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 8.38 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Sep'23

Jun'23

Mar'23

Dec'22

Sep'22

Jun'22

Mar'22

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2023 is 0.00% vs -100.00% in Jun 2023

Standalone Net Profit

QoQ Growth in quarter ended Sep 2023 is -7.19% vs -18.30% in Jun 2023

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2023 is -8.56% vs -7.46% in Jun 2023

Interest

QoQ Growth in quarter ended Sep 2023 is 21.51% vs -16.50% in Jun 2023

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2023 has improved from Jun 2023

Compare Quarterly Results Of Bharat Immunolog With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

0.00

2,396.57

-2,396.57

-100.00%

Other Operating Income

0.00

Total Operating income

0.00

2,396.57

-2,396.57

-100.00%

Raw Material Cost

0.00

179.72

-179.72

-100.00%

Purchase of Finished goods

0.00

445.60

-445.60

-100.00%

(Increase) / Decrease In Stocks

0.00

34.08

-34.08

-100.00%

Employee Cost

3.98

521.79

-517.81

-99.24%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

0.71

474.45

-473.74

-99.85%

Total Expenditure (Excl Depreciation)

4.69

1,655.64

-1,650.95

-99.72%

Operating Profit (PBDIT) excl Other Income

-4.69

740.93

-745.62

-100.63%

Other Income

0.16

69.82

-69.66

-99.77%

Operating Profit (PBDIT)

-4.53

810.75

-815.28

-100.56%

Interest

2.09

199.47

-197.38

-98.95%

Exceptional Items

0.00

Gross Profit (PBDT)

-6.62

611.28

-617.90

-101.08%

Depreciation

0.03

87.03

-87.00

-99.97%

Profit Before Tax

-6.65

524.25

-530.90

-101.27%

Tax

-1.73

107.87

-109.60

-101.60%

Provisions and contingencies

0.00

Profit After Tax

-4.92

416.38

-421.30

-101.18%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

-4.92

416.38

-421.30

-101.18%

Equity Capital

43.18

40.06

3.12

7.79%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

-1.14

10.39

-11.53

-110.97%

Diluted Earnings per share

-1.14

10.33

-11.47

-111.04%

Operating Profit Margin (Excl OI)

0.00%

30.92%

0.00

-30.92%

Gross Profit Margin

0.00%

25.51%

0.00

-25.51%

PAT Margin

0.00%

17.37%

0.00

-17.37%

Public Share Holdings (%)

40.75%

0.00%

40.75

40.75%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 0.00 Cr

in Sep 2023

Figures in Rs Cr

QoQ Growth in quarter ended Sep 2023 is 0.00% vs -100.00% in Jun 2023

YoY Growth in quarter ended Sep 2023 is -100.00% vs 7.21% in Sep 2022

Quarterly - Standalone Net Profit

Standalone Net Profit -4.92 Cr

in Sep 2023

Figures in Rs Cr

QoQ Growth in quarter ended Sep 2023 is -7.19% vs -18.30% in Jun 2023

YoY Growth in quarter ended Sep 2023 is -59.74% vs 67.09% in Sep 2022

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) -4.69 Cr

in Sep 2023

Figures in Rs Cr

QoQ Growth in quarter ended Sep 2023 is -8.56% vs -7.46% in Jun 2023

YoY Growth in quarter ended Sep 2023 is -87.60% vs 28.37% in Sep 2022

Quarterly - Interest

Interest 2.09 Cr

in Sep 2023

Figures in Rs Cr

QoQ Growth in quarter ended Sep 2023 is 21.51% vs -16.50% in Jun 2023

YoY Growth in quarter ended Sep 2023 is 20.11% vs 41.46% in Sep 2022

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 0.00%

in Sep 2023

Figures in Rs %

QoQ Growth in quarter ended Sep 2023 has improved from Jun 2023

YoY Growth in quarter ended Sep 2023 has improved from Sep 2022